<?xml version="1.0" encoding="UTF-8"?>
<p id="Par30">Women who underwent cervical treatment surgery were followed for a median of 50.0 months after treatment (vaccine arm: 49.5, IQR: 32.0–64.0; placebo arm: 50.0, IQR: 30.3–63.5), corresponding to a median of 9 study visits (vaccine arm: 9, IQR: 5–12; placebo arm: 8, IQR: 5–11). The median duration between enrollment and treatment was 17 months for those in the vaccine arm (IQR:4.0–30.0 months) and 17 months for women in the placebo arm (IQR:6.0–34.8 months).</p>
